Seres therapeutics stockholders issue open letter to board of directors regarding reported engagement with nestlÉ

Geneva--(business wire)--lucien selce and mkt capital ltd. (together, “we”), who collectively own 1.4 million shares of seres therapeutics inc. (nasdaq: mcrb) (“seres” or the “company”), today published the following open letter to the company's board of directors (the “board”). *** september 27, 2024 members of the board, we are writing to you today as a stockholder of seres who is seeking additional information regarding the company's planned sale of its vowst business to nestlÉ health scienc.
mcrb Ratings Summary
mcrb Quant Ranking